MUKILTEO, Wash., Sept. 29, 2008 (GLOBE NEWSWIRE) -- Leuchemix Corporation announced that permission to undertake clinical safety trials of its drug LC-1, for leukemia, has been granted and that the sponsored trial will begin shortly.
MUKILTEO, Wash., Sept. 29, 2008 (GLOBE NEWSWIRE) -- Leuchemix Corporation announced that permission to undertake clinical safety trials of its drug LC-1, for leukemia, has been granted and that the sponsored trial will begin shortly.
